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Background: E-cadherin is an adherens junction protein that forms homophilic intercellular contacts in epithelial
cells while also interacting with the intracellular cytoskeletal networks. It has roles including establishment and
maintenance of cell polarity, differentiation, migration and signalling in cell proliferation pathways. Its downregulation
is commonly observed in epithelial tumours and is a hallmark of the epithelial to mesenchymal transition (EMT).
Methods: To improve our understanding of how E-cadherin loss contributes to tumorigenicity, we investigated
the impact of its elimination from the non-tumorigenic breast cell line MCF10A. We performed cell-based assays
and whole genome RNAseq to characterize an isogenic MCF10A cell line that is devoid of CDH1 expression due
to an engineered homozygous 4 bp deletion in CDH1 exon 11.
Results: The E-cadherin-deficient line, MCF10A CDH1-/- showed subtle morphological changes, weaker cell-substrate
adhesion, delayed migration, but retained cell-cell contact, contact growth inhibition and anchorage-dependent
growth. Within the cytoskeleton, the apical microtubule network in the CDH1-deficient cells lacked the radial
pattern of organization present in the MCF10A cells and F-actin formed thicker, more numerous stress fibres in
the basal part of the cell. Whole genome RNAseq identified compensatory changes in the genes involved in
cell-cell adhesion while genes involved in cell-substrate adhesion, notably ITGA1, COL8A1, COL4A2 and COL12A1,
were significantly downregulated. Key EMT markers including CDH2, FN1, VIM and VTN were not upregulated
although increased expression of proteolytic matrix metalloprotease and kallikrein genes was observed.
Conclusions: Overall, our results demonstrated that E-cadherin loss alone was insufficient to induce an EMT or enhance
transforming potential in the non-tumorigenic MCF10A cells but was associated with broad transcriptional changes
associated with tissue remodelling.
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E-cadherin, encoded by the tumor suppressor gene CDH1,
is a homophilic cell-to-cell adhesion protein localized to the
adherens junctions of all epithelial cells [1]. Its cytoplasmic
domain effectively creates a bridge between the cytoskele-
tons of adjacent cells by interacting with both cortical actin* Correspondence: parry.guilford@otago.ac.nz
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unless otherwise stated.filaments and the microtubule network [2]. These and
other interactions [3] extend E-cadherin’s functionality
beyond cell-cell adhesion to roles in establishing and
maintaining cell polarity, differentiation, stemness, cell mi-
gration and the mediation of signalling through various
proliferation and survival pathways including WNT and
EGFR [1-5].
Abrogation of CDH1 expression by mutation, deletion
or promoter hypermethylation is a feature of many epi-
thelial tumours, including prostate, ovarian, lung andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Chen et al. BMC Cancer 2014, 14:552 Page 2 of 14
http://www.biomedcentral.com/1471-2407/14/552hepatocellular carcinomas, and is the hallmark of both
the sporadic and familial forms of diffuse gastric cancer
(DGC) and lobular breast cancer (LBC) [1,6]. In both
LBC and DGC, CDH1 inactivation can be an early initi-
ating event [7,8], whereas in other tumour types includ-
ing prostate, lung, ovarian and colon, its downregulation
is usually considered to be a late event that promotes an
increase in invasive capacity [9]. Increased invasiveness
following CDH1 downregulation is related, at least in
part, to the central role played by E-cadherin in the
de-differentiation process known as the epithelial-
mesenchymal transition (EMT) [10]. During the EMT,
epithelial cells lose polarity and normal cell-cell adhe-
sion, acquiring a mesenchymal phenotype with higher
motility and an increase in cell-extracellular matrix
(ECM) connections [9,11]. The EMT is associated not
only with increased tumor invasion and metastasis, but
also poor outcome, drug resistance and an increase in
the number of cancer stem-like cells [9,12]. E-cadherin
downregulation has been shown to be sufficient to in-
duce an EMT in some [4,9,10,13], but not all [14,15],
cancer cell lines/models. However, it remains unclear
whether its loss can induce an EMT in cells which have
not already undergone malignant transformation [16].
Clues to the influence E-cadherin loss has on tumori-
genesis and the initiation of the EMT come from study of
the multifocal gastric signet ring cell carcinomas (SRCCs)
that occur in Hereditary Diffuse Gastric Cancer (HDGC)
families. HDGC is a familial cancer syndrome caused by
germline mutation of the CDH1 gene and is typified by
highly penetrant DGC and an elevated risk of LBC [17].
With few exceptions, mutation carriers develop tens to
hundreds of gastric foci of SRCC, sometimes with enrich-
ment in the transition zone between the antrum and body
[18]. LBC and lobular carcinoma in situ (LCIS) are also
observed to be multifocal in female mutation carriers (V.
Blair, pers. comm). The multifocal gastric SRCCs are E-
cadherin-negative and almost exclusively stage T1a tu-
mours confined to the lamina propria. Lineage markers
suggest that the foci develop from mucous neck cells that
have invaded through the basement membrane of the
gastric gland [19]. Invasion is likely to be triggered by
inactivation of the wild-type CDH1 allele through mecha-
nisms including promoter hypermethylation [6]. In one
model [20], E-cadherin loss creates instability in the orien-
tation of the mitotic spindle, leading to a proportion of
the cell divisions occurring out of the epithelial plane with
subsequent displacement of daughter cells into the lamina
propria. The multifocal SRCC foci in the gastric mucosa
are known to be relatively indolent, but show unpredict-
able progression to advanced disease. A small percentage
of foci show characteristics of an EMT, and this change is
associated with tumour progression [19]. However, the
absence of an EMT-like phenotype from the majority ofSRCC foci suggests that E-cadherin loss alone is insuffi-
cient to induce an EMT in this relatively normal genetic
background.
MCF10A is a spontaneously immortalized, non-
transformed mammary epithelial cell line derived from hu-
man fibrocystic tissue. Although it does carry cytogenetic
abnormalities associated with in vitro cultured mammary
epithelial cells, including p16 and p14ARF deletion and
MYC amplification [21], MCF10A is considered a “normal”
breast epithelial cell due to its near diploid, stable karyotype
and characteristics of normal breast epithelium such as
lack of tumorigenicity in nude mice, lack of anchorage-
independent growth [22] and ability to form mammo-
spheres in culture [21]. Here we have used cell-based
assays and whole genome RNAseq to characterize an
isogenic MCF10A cell line that is devoid of CDH1 ex-
pression due to an engineered homozygous 4 bp dele-
tion in CDH1 exon 11. We show that E-cadherin loss
disrupts the organization of the cell’s actin and micro-
tubule cytoskeletons and modifies its adherence and




MCF10A cells (product no: CRL 10317), a non tumorigenic
mammary epithelial cell line, and the derived isogenic
line with CDH1 knock out (MCF10A CDH1-/-) using
CompoZr ZFN technology (product no: CLLS1042)
were purchased from Sigma. The MCF10A isogenic
lines were cultured in DMEM/F12: (1:1) (Invitrogen)
with 5% horse serum (Invitrogen), 10 μg/ml Actrapid
Penfil neutral insulin (Novo Nordisk Pharmaceuticals
Ltd), 20 ng/ml human epidermal growth factor (Pepro-
tech), 100 ng/ml cholera toxin, and 500 ng/ml hydro-
cortisone (Sigma) [21]. Cells were grown at 37°C with
5% CO2, seeded into T75 flasks at densities of 3.0 × 10
5
and 4.5 × 105, respectively and passaged at 90% con-
fluency (~3 days) for a maximum of ten passages
(http://brugge.med.harvard.edu/protocols).
Western blot
MCF10A and MCF10A CDH1-/- cells were grown for 72 h
to 90% confluency in T25 flasks and lysed using cell culture
lysis reagent (Promega) containing cOmplete mini protease
inhibitor (Roche). BCA assays (Thermo) were performed to
equalize total protein loaded. Proteins were separated on
10% SDS-PAGE gel for 2 h, followed by blot transfer at
100 V for 1 h. Immunoblotting was performed using rabbit
anti-E-cadherin antibody (Santa Cruz, SC7870) at 1:200
dilution overnight, or rabbit anti-α-actin primary antibody
(Sigma) at 1:1,500 dilution overnight followed by anti-
rabbit HRP-linked secondary antibody (Santa Cruz) at
1:5,000 dilution for 1 h. Chemiluminescence was performed
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LAS-3000 (Fujifilm).
Immunofluorescence
MCF10A and MCF10A CDH1-/- cells were seeded on
Coverglass slides (Labtek) and grown to confluence for
72 h. Cells were fixed with 4% paraformaldehyde then
permeabilized with 0.2% Triton-X100 in PBS for 5 min
at room temperature. Cells were blocked with 10% FBS
in PBS for 1 h at room temperature. E-cadherin primary
antibody (Santa Cruz, SC-7870) used at 1:250. Anti-
rabbit secondary antibody conjugated with AlexaFluor-
488 (Invitrogen) used at 1:750. Immunofluorescence
images were acquired with an Olympus IX71 micro-
scope, under 40× objective.
Proliferation assay
MCF10A and MCF10A CDH1-/- cells were seeded at
densities of 2.0 × 103 and 4.0 × 103 in three replicates in
96 well E-plates and incubated at 37°C in 5% CO2. The
growth rate was monitored in real time at 15 min inter-
vals for 96 h using the xCELLigence platform (Roche).
Both cell lines were also seeded at the same densities
into 96 well flat clear bottom black plates (Corning) and
grown at 37°C in 5% CO2 and imaged every 2 h for 96 h
using the IncuCyte 2011A FLR (Essen Bioscience). Con-
fluency was determined using the IncuCyte software
Confluence v1.5.
Cell adhesion assay
Cell adhesion assays were performed using the IncuCyte
2011A FLR. MCF10A and MCF10A CDH1-/- cells were
seeded in six replicates at 2.0 × 104 cells per well in 96
well flat clear bottom plates (Greiner Bio-one) with dif-
ferent surface coatings: no coating for the uncoated,
2 μg/ml collagen (Sigma), 2 μg/ml fibronectin (BD Bio-
science), 8 μg/ml vitronectin (Invitrogen), 8 μg/ml laminin
(Invitrogen) and grown at 37°C, 5% CO2. Images were ac-
quired every 2 h for 8 h using the automated image acquisi-
tion software. Cell numbers at each time point were also
determined using the Cell Counter plugin (http://rsbweb.
nih.gov/ij/plugins/cell-counter.html) in ImageJ [23].
Scratch wound assay
Scratch wound assay was performed using the IncuCyte
2011A FLR (Essen Bioscience). Briefly, MCF10A and
MCF10A CDH1-/- cells were seeded in six replicates at
densities of 2.5 × 104 and 3.5 × 104 cells per well, re-
spectively, in 96 well Essen ImageLock Plate (Essen
Bioscience) with different coating surfaces: no coating
for the uncoated condition, 2 μg/ml collagen, 2 μg/ml
fibronectin, 8 μg/ml vitronectin, 8 μg/ml laminin. Cells
were incubated at 37°C and 5% CO2 and grown to
100% confluency. The usage of the Essen imageLockplates ensures wounds are automatically located and
registered by the IncuCyte software and analyzed using
wound confluence metrics. Precise and reproducible
wounds were generated using the 96 PTFE pin Wound-
Maker (Essen Bioscience) on the confluent monolayer
and cells returned to the incubator where images of cells
were acquired every 1 h for 35 h under phase contrast mi-
croscopy. Wound confluence was graphed over time to
quantitatively evaluate the characteristic of wound closing
using the IncuCyte software, Wound Confluence v1.5.Soft agar assay
An overlay of 2.0 × 104 MCF10A and MCF10A CDH1-/-
cells and 2.0 × 103 MCF7 cells in 0.35% agar in medium
were plated over a base layer of 0.5% agar (Applichem)
and grown at 37°C with 5% CO2. Growth medium was
added the next day and replenished twice a week. After
24 days, growth medium was removed and MTT (Sigma)
solution was added (final concentration 2 mg/ml), and the
plates further incubated at room temperature for 4 h with
gentle shaking. The MTT solution was then removed and
washed. Images were taken using Image Scanner 3 and col-
onies counted. The experiment was performed with at least
two technical replicates for each cell line.Immunofluorescence confocal microscopy
MCF10A and MCF10A CDH1-/- cells were seeded on
glass coverslips coated with fibronectin (Becton Dickinson)
and allowed to grow to confluence for 48-72 h. Cells were
fixed with ice-cold methanol for 5 min on ice for micro-
tubule staining or fixed with 4% paraformaldehyde in
cytoskeleton stabilization buffer (10 mM PIPES pH 6.8,
100 mM KCl, 300 mM sucrose, 2 mM EGTA, 2 mM
MgCl2) on ice for 20 min and then permeabilized with
0.25% Triton-X100 in PBS for 5 min at room temperature
for F-actin staining. Cells were blocked with 5% milk in
PBS for 1 h at room temperature. Primary antibodies used:
mouse monoclonal antibody (mAb) directed against the
ectodomain of E-cadherin (HECD-1) (a gift from Peggy
Wheelock, University of Nebraska, Omaha, NE; with
the permission of M. Takeichi) 1:50; rabbit polyclonal
Ab (pAB) against E-cadherin (generated in-house) [24]
1:1000; rat monoclonal [YOL1/34] antibody against tubulin
(Abcam, # ab6161); 1:100 rabbit polyclonal antibody against
ZO-1 (Invitrogen, # 61-7300). F-actin was stained with
AlexaFluor 488-phalloidin, 1:500 (Invitrogen). Secondary
antibodies were species-specific antibodies conjugated with
AlexaFluor-488, -594 or -647 (Invitrogen) for immunofluor-
escence (1:500). For immunofluorescence, confocal images
were acquired with a Zeiss 710 Meta laser scanning con-
focal microscope, with a 60× objective, 1.4 NA oil Plan
Apochromat immersion lens with 0.6-1.0 μm optical sec-
tions. Contrast adjustment and z-projections of raw images
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Health) [23] and Illustrator (Adobe).
RNASeq
MCF10A and MCF10A CDH1-/- cells were seeded at
densities of 2.0 × 105 and 3.5 × 105 cells respectively in
duplicate in a six well dish and grown until 70% con-
fluency, with a medium change at 24 h. Total RNA was
extracted at 48 h post seeding using quick-RNA Miniprep
Kit (Zymo) according to the manufacturer’s protocol. RNA
yield and purity were assessed using Qubit (Invitrogen) and
the Agilent 2100 Bioanalyser. cDNA library preparation
was performed by New Zealand Genomics Limited using
Illumina TruSeq RNA preparation version 2.0. Each library
had inserts of 200 bp and sequence reads were generated
from one lane of an Illumina HiSeq™ 2000 run. Bowtie2
and Cufflinks version 2.0.1 software packages were used to
align the read data to human genome build GRC37 and
annotated with BiomaRt using Ensembl dataset ”hsapiens_-
gene-_ensembl”. Unannotated genes were removed and
remaining count data was normalized using EdgeR [25].
The per gene read counts were imported into the statistical
software package R (www.r-project.org), and analyzed using
the functionality included in the edgeR and limma
packages. Briefly, TMM (trimmed mean of M values)
normalization was applied to generate normalized
count data, and the lmFit command was used to fit a
linear model to the data for each gene. Normalized
data were converted to log-cpm (counts per million
reads) prior to analysis using the voom command in
limma. Differential expression results for MCF10A
CDH1-/- vs MCF10A were written to CSV files, view-
able in Excel (limma moderated t- statistic produced for
each comparison, per gene, with FDR p value adjustment
applied). Gene Ontology (GO) functional enrichment ana-
lysis was carried out using GATHER [26].
Results
Characterization of MCF10A CDH1-/- appearance and
growth characteristics
A MCF10A CDH1-/- cell line carrying a homozygous 4 bp
deletion in exon 11 of CDH1 has recently been developed
using zinc finger nuclease (ZFN) technology (Sigma-Aldrich,
Saint-Louis). The 4 bp deletion (Figure 1a) at mRNA
position 1820-1823 results in a frameshift predicted to give
rise to a premature termination codon at position 1868,
generating a truncated protein of 582 amino acids that
lacks the extracellular cadherin repeat 4 domain, trans-
membrane region and cytoplasmic domain. Immunoblot-
ting and immunofluorescence confirmed the absence
of E-cadherin expression from the MCF10A CDH1-/-
line (Figure 1b-c; Additional file 1: Figure S1). Subcon-
fluent MCF10A CDH1-/- cells exhibited a more rounded
morphology and grew in a clustered and contracteddistribution distinct from the wildtype MCF10A which had
a more elongated morphology (Figure 1d). At full conflu-
ence, both MCF10A and MCF10A CDH1-/- cells retained
cobblestone morphology typical of epithelial cell lines. The
MCF10A CDH1-/- cells however, presented gaps, unlike
the even monolayer distribution observed in wildtype
MCF10A (Figure 1d). Both the MCF10A and the MCF10A
CDH1-/- cells maintained normal contact growth inhibition
(Figure 1d).
To estimate the effect of E-cadherin loss on the growth
kinetics of the MCF10A cells, the isogenic pair of cell lines
were seeded at a density of 2.0 × 103 and 4.0 × 103 cells
per well in 96 well E-plates and growth followed using
the xCELLigence real time system (Roche, Basel). The
MCF10A CDH1-/- cells showed a prolonged lag phase
when compared to the wildtype MCF10A cells (Figure 1e).
However, once both cell lines achieved log phase growth,
the doubling time of the two lines was almost identical with
MCF10A being only slightly shorter (13 h) compared to the
MCF10A CDH1-/- cells (14 h) (Figure 1e).
We also performed scratch wound assays to measure
cell migration in real-time over 35 h post wounding.
Wound closure was quantitatively evaluated over time
using Wound Confluence v1.5 (time point t = 0 h, corre-
sponds to 2.5 h post wound generation). MCF10A
CDH1-/- cells migrated markedly slower and took longer
to close the wound (t = 27.4 ± 4.1 h) compared to wild-
type cells (t = 15.0 ± 1.6 h) (Figure 1f ).
Finally, the number of nucleoli present per cell were
noticeably reduced in MCF10A CDH1-/- compared to
wildtype: 87% of MCF10A CDH1-/- cells have one or two
nucleoli per cell compared to 42% of MCF10A cells
(Additional file 2: Figure S2). The majority of wildtype
MCF10A cells (57%) had three or more nucleoli compared
to 12% of MCF10A CDH1-/- cells (Additional file 2: Figure
S2). The reduction in nucleoli number is suggestive of a
decreased demand or capability for ribosome biogenesis.
Loss of CDH1 does not enable anchorage-independent
growth
To determine if E-cadherin loss would cause MCF10A cells
to become tumorigenic, we performed soft agar colony for-
mation assays to monitor anchorage–independent growth.
After 24 days in soft agar, no colonies were formed for
MCF10A cells, consistent with a previous study [22]. Like-
wise, MCF10A CDH1-/- cells did not show any colony
growth (Figure 1g). This result showed neither MCF10A
nor MCF10A CDH1-/- cells exhibit the ability to divide and
proliferate in the absence of adhesion to the substratum.
MCF10A CDH1-/- cells show altered actin and tubulin
cytoskeletal arrangement
To directly observe the effects of E-cadherin knock-out
on the cytoskeleton of MCF10A cells, we examined the
Figure 1 (See legend on next page.)
Chen et al. BMC Cancer 2014, 14:552 Page 5 of 14
http://www.biomedcentral.com/1471-2407/14/552
(See figure on previous page.)
Figure 1 Characterization of MCF10A CDH1-/- cells. a) CDH1 sequence from MCF10A CDH1-/- and wildtype MCF10A cell lines depicting the
engineered 4 bp deletions as determined by RNAseq. The specified deletion was attributed to ZFN editing on exon 11 of both CDH1 alleles in
MCF10A CDH1-/- cells. The ZFN binding site is represented by bases in red uppercase and the ZFN cut site is represented in red lowercase. b)
Immunoblot of MCF10A CDH1-/- confirming the loss of E-cadherin expression as a result of the 4 bp deletion with α-actin as loading control. The
cropped images are a composite of the same nitrocellulose immunobloted with antibodies against E-cadherin followed by α-actin (Additional file
1: Figure S1). c) Immunofluorescence showing loss of E-cadherin from the cell junctions in MCF10A CDH1-/- but not wildtype MCF10A cells. d)
Comparison of growth morphology between MCF10A CDH1-/- and wildtype at subconfluence and full confluence. At subconfluence, MCF10A
CDH1-/- showed clustered and contracted distribution while some wiltdtype MCF10A cells exhibited more mesenchymal morphology. At full
confluence, both isogenic cells retained epithelial cobblestone-like morphology, although MCF10A CDH1-/- displayed gaps not observed in
wildtype cells. e) Comparing cell proliferation profile between both MCF10A isogenic cells. A measure of cell proliferation was represented by
the normalized cell index taken from impedence measurements generated by cells grown over 96 h on a 96-well E-Plate on the xCELLigence. f)
The time course of cell migration was quantified using IncuCyte wound confluence at 1 h intervals over 35 h. MCF10A CDH1-/- cells were shown
to take significantly longer in wound closing compared to wildtype cells. g) Soft agar assay to determine anchorage-independent growth as a
result of E-cadherin loss. Anchorage-independent growth was observed only in the positive control MCF-7 cells, but not in either of the MCF10A
isogenic cells. Representative images from one of two biological replicates were presented.
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escence staining for α-tubulin and F-actin. On the apical
surface of MCF10A cells, the microtubules displayed a
prominent radial pattern of organization with minus
ends anchored densely in the centre and the plus ends
extending towards the cell cortex (Figure 2a). However
in MCF10A CDH1-/- cells, the microtubules were less
dense and there was a gross defect in the radial pattern
of organization, often oriented parallel to the cell cortex
(Figure 2a). At the basal surface of the cells, the microtu-
bules formed a meshwork-like structure and no striking dif-
ferences in organization between MCF10A and MCF10A
CDH1-/- cells were observed. Apically in MCF10A cells,
actin forms a cross-linking filamentous meshwork while
basally it organizes itself into stress fibre like structures
(Figure 2b). The apical actin meshwork looked similar
in MCF10A CDH1-/- cells, but basally the stress fibres
were thicker and more numerous in the E-cadherin-
deficient cells.
Loss of CDH1 impacts on the transcription of diverse cell-
cell adhesion genes
To elucidate the impact of E-cadherin loss at the tran-
scriptional level, we performed genome-wide RNAseq
on the MCF10A and MCF10A CDH1-/- cells. An
average of 6.55 × 107 reads were obtained per library.
Using a cut off of +/- log21.00 and an adjusted p value
of <0.05, a total of 1,388 genes were observed to be dif-
ferentially regulated. Relative to the CDH1-expressing
cells, 715 genes showed significantly increased expres-
sion in the CDH1-/- cells and 673 genes had signifi-
cantly reduced expression. The GO terms [26] most
strongly associated with the 1,388 genes included mor-
phogenesis (Bayes factor 34.1), organogenesis (Bayes
factor 31.5), development (Bayes factor 30.3), cellular
metabolism (Bayes factor 27.8), cell communication
(Bayes factor 24.0), cell adhesion (Bayes factor 21.3)and histogenesis (Bayes factor 18.5) (Additional file 3:
Table S1).
Loss of CDH1 expression was associated with expression
changes in other cell-cell adhesion genes
Four other cadherins showed significant changes in ex-
pression: CDH2 and CDH4 were downregulated in the
CDH1-/- cells by >2 fold, whereas CDH3 and CDH16
were upregulated by up to 3.8 fold. Three of the four
nectin genes which encode proteins involved in adhe-
sion at the adherens junction were also markedly up-
regulated by up to 2.2 fold, most notably PVRL4.
Genes encoding adherens junction-associated proteins
(e.g. CTNNB1) showed little or no change in expres-
sion in the MCF10A CDH1-/- cells (Additional file 4:
Table S2). Ten established tight junction genes showed
significant upregulation with five demonstrating up-
regulation of >2 fold namely, CLDN1, CLDN4, CLDN7,
OCLN and CGN (Table 1). Two further tight junction
genes showed significant downregulation (JAM3 1.3
fold decrease, p = 0.004 and CLDN15 2.0 fold decrease,
p = 0.015), three others had insignificant changes (TJP1
1.2 fold decrease, p = 0.154; TJP2 1.1 fold increase, p =
0.054 and CLDN22 1.1 fold, p = 0.74), while 17 showed
negligible expression in both cell lines (Additional file
4: Table S2). Similarly, eight of the eleven expressed
desmosome genes and six of the eight expressed gap
junction genes also demonstrated increased mRNA ex-
pression, most notably DSG4, DSC2, JUP, GJA5, GJB2
and GJB4, with fold changes up to 3.9 fold (Table 1).
Taken together, this transcriptional data demonstrates
that the loss of CDH1 from the adherens junction is as-
sociated with an increase in the expression of genes en-
coding various tight junction, desmosome and gap
junction proteins. This increased expression of other
cell-to-cell adhesion genes may partially compensate
for the loss of E-cadherin and explains the retention of
Figure 2 (See legend on next page.)
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Figure 2 E-cadherin loss altered cytoskeletal organization in MCF10A CDH1-/- cells. a) Loss of E-cadherin altered tubulin cytoskeletal
arrangement. On the apical surface of MCF10A cells, the microtubules showed radial pattern of organization (indicated by white arrows) with
the minus end densely anchored in the centre and the plus end extending towards the cell cortex. However, in MCF10A CDH1 -/- cells had gross de-
fect in the radial pattern of organization and often oriented parallel to the cortex (indicated by white arrows). At the basal surface, the microtubules
form a meshwork like structure with no striking difference observed between the two cell lines. b) Loss of E-cadherin altered actin cytoskeletal
arrangement. On the apical surface of MCF10A cells, actin forms cross-linking filamentous meshwork while basally it organizes itself into stress
fibres like structure. Overall apical actin meshwork looks similar in both MCF10A isogenic cells but basally there are more and thicker stress
fibres in MCF10A CDH1-/- cells (indicated by white arrows).
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observed at full confluency (Figure 1d).
Loss of CDH1 from MCF10A cells alters expression of the
genes involved in cell-ECM adhesion and promotes al-
tered adhesion to basement membrane proteins
In addition to the observed changes in expression of
cell-to-cell adhesion genes, the loss of CDH1 was also asso-
ciated with significant changes in the expression of cell-
substrate adhesion genes (Table 1). Up to 2.8 fold reduction
in the expression of the integrin receptor subunit genes
ITGA1, ITGA4, ITGA5, ITGAV, ITGB1, ITGB2 was ob-
served. Only ITGA10 and ITGB6 showed significantly
increased expression (up to 2 fold; Additional file 5:Table 1 Expression profile of cell adhesion genes in MCF10A
Cell-cell adhesion genes Cell-ECM adhe
Gene FC Adj. p value Gene FC
CLDN1 3.1 3.45E-05 COL2A1 5.3
CLDN4 3.8 4.87E-05 COL4A1 -2.6
CLDN7 2.7 1.51E-05 COL4A2 -2.5
OCLN 2.9 2.27E-05 COL4A4 -2.9
CRB3 2.1 5.38E-04 COL5A3 3.6
CGN 3.0 1.80E-04 COL6A3 -3.5
(CDH1) -10.0 9.10E-06 COL7A1 2.0
CDH2 -2.2 2.37E-04 COL8A1 -6.3
CDH3 1.8 1.51E-05 COL12A1 -4.3
CDH4 -2.9 7.79E-04 COL13A1 6.1
CDH16 3.8 6.73E-04 COL18A1 -2.4
PVRL4 2.2 1.01E-04 COL27A1 -6.3
DSG4 3.0 9.73E-04 COL28A1 -34.1
DSC2 2.2 2.87E-05 LAMA1 -2.5
JUP 2.0 8.71E-06 LAMA2 2.3
GJA5 2.1 1.13E-02 FN1 -7.2
GJB2 3.9 3.88E-06 ITGA1 -2.8
GJB4 3.2 7.10E-04 ITGA10 2.0
ICAM1 -3.6 8.31E-03 ITGB1 -1.4
The CDH1 transcript level in MCF10A CDH1-/- cells was markedly reduced by more
consistent with nonsense-mediated decay. The table contains a selection of genes
genes with a significant fold change ≥2.0. Other genes with fold change <2.0 are li
the fold change relative to MCF10A wildtype expression.Table S3). Furthermore, many ECM transcripts demon-
strated a marked downregulation in the MCF10A CDH1-/-
cells compared to the wildtype cells. This was evident for
COL4A1, COL4A2, COL4A4, COL6A3, COL8A1, COL12A1,
COL18A1, LAMA1, FN1 and VTN. Other members of the
laminin family LAMA5, LAMB1, LAMB2 and LAMC1
were also significantly downregulated (Additional file 5:
Table S3). Only a small subset of ECM genes were up-
regulated in MCF10A CDH1-/- cells, namely COL2A1,
COL5A3, COL7A1, COL13A1 and LAMA2 (Table 1).
Genes encoding focal adhesion components that form
linkages between integrins and the actin cytoskeleton
were also markedly downregulated (Table 1). TLN1 and
TLN2, encoding the talin proteins, are key componentsCDH1-/-
sion genes Focal adhesion genes
Adj. p value Gene FC Adj. p value
3.22E-04 TLN1 -1.5 1.48E-02
3.45E-05 TLN2 -2.0 5.72E-03
4.88E-05 TNS1 -5.5 7.34E-05
2.04E-02 TNS3 -2.3 2.77E-04
1.07E-03 UTRN -2.4 1.13E-02
2.86E-03 DLC1 -2.2 1.19E-03
3.11E-03 ACTN1 1.0 4.98E-01
1.12E-05 ACTN4 1.1 3.03E-01
4.48E-04 VCL -1.1 4.20E-01
1.07E-04 ACTB 1.2 2.66E-02
4.07E-04 ACTG1 1.3 8.62E-04
7.07E-04 TUBB2A 1.3 6.73E-03
4.93E-03 PTK2 1.1 1.48E-02
8.51E-04 SRC -1.3 2.29E-02
4.77E-04 ILK 1.0 4.20E-01
1.78E-04 RAC1 1.1 2.29E-02
6.37E-04 RHOA 1.1 1.89E-02
6.92E-04 ROCK1 -1.3 4.28E-02
2.91E-04 PXN -1.1 1.65E-02
than 90% compared to the wild type CDH1 transcript in MCF10A cells,
involved in cell-cell adhesion, cell-ECM adhesion and focal adhesion including
sted in the Additional file 4: Table S2 and Additional file 5: Table S3. FC denotes
Figure 3 E-cadherin loss contributes to reduced substrate adhesion in MCF10A CDH1-/-. Both isogenic cell lines were seeded at a density
of 2.0 × 104 cells and images were taken at 2 h intervals for up to 8 h using the IncuCyte 2011A FLR. a) Representative images of cell substrate
adherence at 4 h post seeding under uncoated conditions. b) Histogram representing the number of adhered to non-adhered cells from both
cell lines under uncoated conditions over different time points. Significantly reduced substrate adhesion were observed in MCF10A CDH1-/- cells
as determined by student t-test p < 0.01 (represented by **). c) Histogram representing the number of adhered to non-adhered cells from both
cell lines under different ECM coating conditions (UC, uncoated; COL, collagen; LN, laminin; FN, fibronectin; VN, vitronectin) at 4 h post seeding.
For each condition, three images were acquired and the population of non-adhered cells to total cell numbers from each image were counted
by two independent researchers and the average taken. Results of experiments done under different ECM coatings showed MCF10A CDH1-/- cells
consistently showed reduced substrate adhesion compared to the wildtype cells (student t-test; p < 0.01 represented by **). Furthermore, different
ECM coatings provided varying increases in the numbers of adhered cells in both isogenic cells.
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integrins and actin directly or indirectly via vinculin and
α-actinin [27]. Both were downregulated by 1.5 fold and
2.0 fold respectively. However, vinculin (VCL) and α-
actinin (ACTN1, ACTN4) themselves did not show any
significant expression changes. Additionally, genes en-
coding the tensin proteins which mediate integrin and
actin linkages during focal adhesion disassembly [28],
TNS1 and TNS2 were also significantly downregulated
by 5.5 and 2.3 fold respectively. UTRN a gene which en-
codes utrophin, a protein localized to the adherens junc-
tion which form linkages to actin [29], was also
significantly downregulated by 2.4 fold. In contrast,
modest upregulation (up to 1.3 fold) was observed in the
genes encoding the actin and microtubule cytoskeletal
proteins ACTB, ACTG1 and TUBB2A mRNA. While
the expression of certain key genes (SRC, PTK2, ILK,
PXN, RHOA) involved in regulating focal adhesion
maturation and turnover showed modest expressionchanges, DLC1 which encodes a rhoGAP protein that
regulates small GTP binding proteins at focal adhesion
sites was downregulated by 2.2 fold.
To examine this apparent deficit in cell-substrate ad-
hesion in MCF10A CDH1-/- cells at the intact cell level,
MCF10A and MCF10A CDH1-/- cells were plated at an
equal density in 96 well uncoated plates and the total
number of adherent and non-adherent cells counted
after 2, 4 and 8 h. While the proportion of non-adherent
cells from both lines decreased with time, their number
was significantly higher in MCF10A CDH1-/- cells at all
three time points (Figure 3a-b) indicating reduced cell-
ECM adhesion. This defect in the uncoated substrata
might have been due to either decreased matrix secre-
tion and/or decreased integrin expression. To pursue
this, we then tested if adhesion could be rescued by
pre-coating substrata with matrix proteins. We observed
that adhesion to coated substrata is still reduced in E-
cadherin deficient cells compared to wildtype MCF10A
Figure 4 (See legend on next page.)
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Figure 4 E-cadherin loss compromises cell migration of MCF10A CDH1-/-. Both isogenic cell lines were grown to confluence in complete
media, wounds were generated using the 96-well WoundMaker and the data collected over 35 h and analyzed on the IncuCyte. a) Representative
wounds on MCF10A isogenic cells under different ECM conditions at the start (immediately after wounding) and 14 h post wounding. b) The
time course of cell migration was quantified using wound confluence at 1 h intervals over 35 h. MCF10A CDH1-/- cells were shown to take
significantly longer in wound closing compared to wildtype cells under different coating conditions.
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was observed with collagen (p = 0.0006), followed by
laminin (p = 0.01), fibronectin (p = 0.04), and vitronec-
tin (p = 0.08). Increased adhesion was also observed in
the MCF10A parent cells (Figure 3c) with the most sig-
nificant gains being with collagen (p = 2.2 × 10-7),
followed by fibronectin (p = 3.53 × 10-4), laminin (p =
0.03), and vitronectin (p = 0.12). While part of the de-
fect seen in Figure 3b may be due to failure of matrix
secretion, it does not explain the whole phenomenon
which might be due to decreased integrin expression. Coat-
ing plates with either collagen, fibronectin, vitronectin or
laminin alone also increased MCF10A CDH1-/- cell migra-
tion as observed in the wound closure assay compared to
uncoated wells (Figure 4a-b) but slower compared to wild-
type [30]. Gains in migration were less marked in MCF10A
wildtype cells (Figure 4b). The increased adhesion and mi-
gration of MCF10A CDH1-/- cells on ECM protein-coated
slides is consistent with the reduced cell-substrate adhesion
observed in E-cadherin-negative cells being mediated at
least in part by the downregulation of ECM proteins and
their associated integrins.
Loss of CDH1 from MCF10A cells does not induce a
coherent change in the expression of EMT-associated
genes
The EMT is characterized by the downregulation of epi-
thelial markers-typically including cytokeratins 8, 9 and
18, and various tight junction proteins and the coordi-
nated upregulation of mesenchymal markers includingTable 2 The relative expression of EMT genes in E-cadherin d
Epithelial markers Mesenchymal
Gene FC Adj. p value Gene FC
KRT8 1.4 7.67E-04 CDH2 -2.2
KRT9 2.5 2.89E-02 CDH11 1.4
KRT18 1.4 3.86E-04 VIM 1.1
CLDN1 3.1 3.45E-05 FN1 -7.2
OCLN 2.9 2.27E-05 VTN -1.3
TJP3 1.9 4.69E-04 CTNNB1 1.0
CGN 3.0 1.80E-04 ACTA2 1.0
DSP 1.0 9.87E-01 ITGA5 -1.2
SDC1 1.6 3.11E-05 ITGAV -1.4
Genes with significant ≥2.0 fold gene expression changes are presented with inclus
Additional file 5: Table S4. FC denotes the fold change relative to MCF10A wildtypeN-cadherin (CDH2), vimentin (VIM), ECM proteins and
matrix metalloproteinases (MMPs). To explore the abil-
ity of E-cadherin loss to induce an EMT in isolation of
other genetic changes, we mined the relative expression of
well characterized EMT genes and their transcriptional
regulators in MCF10A and MCF10A CDH1-/- cells. None
of cytokeratins 8, 9, or 18 were downregulated in the
MCF10A CDH1-/- cells (Table 2), and as mentioned above,
there was a notable trend for tight junction genes such as
CLDN1, OCLN, TJP3, and CGN to be upregulated rather
than downregulated (Table 1). Further to the observed
trend towards lower expression of ECM genes in the
CDH1-deficient cells, none of the mesenchymal markers
CDH2, CDH11, VIM, FN1, S100A4, VTN nor ACTA2
showed significantly increased expression in the MCF10A
CDH1-/- cells. Although S100A4 expression was not sig-
nificantly changed, 12 other members of the S100A calcium
binding protein family (from a total of 16 S100A; Additional
file 6: Table S4) showed increased expression, including
S100A8 (4.1 fold) and S100A7 (7.0 fold). The upregulation
of transcription factors SNAI1, SNAI2, TWIST1, TWIST2,
ZEB1 and ZEB2 that are known to promote the EMT and
repress CDH1 expression [9] were themselves unchanged
or strongly downregulated in the case of ZEB2 (Table 2;
Additional file 7: Table S5) suggesting the existence of a
feedback loop from CDH1. Although the overall trend of
the epithelial and mesenchymal markers was opposite to
that which would occur during an EMT, the MCF10A
CDH1-/- cells did show a significant increase in the expres-
sion of MMP9 and 14. This trend towards increasedeficient MCF10A cells
markers EMT Transcription factors
Adj. p value Gene FC Adj. p value
2.37E-04 SNAI1 -2.5 1.38E-02
3.11E-01 SNAI2 1.0 5.83E-01
6.12E-02 TWIST1 -1.1 3.58E-01
1.78E-04 TWIST2 -1.2 4.20E-01
6.07E-01 ZEB1 -1.7 1.23E-02
4.20E-01 ZEB2 -7.3 5.02E-05
9.12E-01 AKT2 -1.1 8.54E-02
8.75E-03 MMP1 5.8 1.45E-02
2.11E-02 MMP9 3.3 9.08E-04
ion of certain key genes. For other ECM genes with fold change <2.0, refer
expression.
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pression of the metalloprotease inhibitors TIMP2-3 and the
increased expression of 10 members of the kallikrein family
of proteases (Additional file 6: Table S4). Taken together,
these results do not support E-cadherin loss alone being
sufficient to induce a coordinated shift to a mesenchymal
phenotype, however they do provide evidence for a direct
link between E-cadherin regulation and aspects of tissue
remodelling.
Discussion
CDH1 is widely considered to be an ‘invasion suppressor
gene’ whose inactivation is associated with tumor pro-
gression. However, the identification of large numbers of
early stage gastric and breast cancers in CDH1 germline
mutation carriers [18,31] demonstrates that E-cadherin
loss can also influence the initiation of cancer. To pro-
vide a better understanding of the impact of E-cadherin
loss in a non-malignant genetic background, we have
characterized an E-cadherin-deficient cell line that has
been derived from the non-tumorigenic breast line
MCF10A using zinc finger nuclease technology.
MCF10A CDH1-/- cells largely retained an epithelial
cobblestone morphology, although slightly more rounded
cells and gaps were observed in the confluent monolayer
when compared to wildtype cells. Our transcription analysis
suggests that the retention of cell adhesion appears to be
associated with compensatory changes in other cell-cell
adhesion proteins localized at desmosomes, tight junctions
and adherens junctions, including P-cadherin (CDH3).
Similarly, the targeted loss of E-cadherin from murine skin
epithelium is also not associated with a significant loss of
cell-cell adhesion, an effect attributed to compensatory up-
regulation of P-cadherin and desmosomal cadherin in the
basal layer [32,33]. Despite the loss of E-cadherin from the
adherens junction, a level of normal cell polarity is retained
in the MCF10A CDH1-/- cells, based on the apical ZO-1
localization (Figure 2b) and the ability of these cells to form
luminal cores in 3D matrigel culture (data not shown). This
is consistent with the polarity retention observed in the
conditional knockout mouse whereby E-cadherin loss
in the epidermis did not alter Par3 and Scribble
localization [34]. However, E-cadherin depletion dis-
rupts cell polarization in MDCK cells [35] and can lead
to abnormal mitotic spindle orientation in different
model systems [20].
The cadherin adhesion complex interacts dynamically
with the actin and microtubule cytoskeletons through
various multiprotein complexes, allowing mechanosensing,
force transmission, vesicle mediated transport of junctional
proteins to the zonula adherens, and the regulation of
microtubule stability and orientation [2]. CDH1-deficient
MCF10A cells lacked the radiating microtubule structure
observed on the apical side of the wildtype cells (Figure 2a),consistent with a disruption of either plus-end or minus-
end microtubule anchoring at the adherens junctions,
[36-38]. Not surprisingly, this microtubule reorganization
was also associated with downregulation of genes involved
in the adherens junction-microtubule axis including KIFC3,
a gene involved in microtubule minus-ends directed motor
found to localize to both the zonula adherens and centro-
some and also NIN which encode ninein, involved in an-
chorage to the centrosome.
E-cadherin loss caused no evident difference in the
organization of F-actin in the apical region of the MCF10A
cells. However, in the basal region there was an increased
prominence of stress fibers (Figure 2b) suggesting that basal
contractility and traction forces (driven by Rho signalling)
might be potentiated. Similar thickening and lengthening of
actin stress fibres have been observed in mouse mammary
epithelial, NMuMG cells following TGF-β induced EMT
[39]. Associated transcriptional changes in the E-cadherin-
deficient cells, included upregulation of RhoA, RhoB and
RhoC, although their downstream effectors ROCK1 and
ROCK2 were downregulated.
One striking characteristic of the CDH1-deficient
MCF10A cells was the reduction in cell-substrate ad-
hesion. Multiple transcriptional changes consistent
with this phenotype were observed, including the
downregulation of genes encoding ECM proteins [40],
integrin subunits and focal adhesion proteins involved
in linking integrins with actin stress fibers such as
talin, paxillin, tensin and P130Cas. The most marked
integrin downregulation was of ITGA1, ITGA4, ITGA5,
ITGAV, ITGB1 and ITGB2, genes that encode subunits
of the α1β1, α2β1, α3β1, α4β1, α5β1, αvβ1, α1β2 integ-
rin receptors, respectively [27]. The crosstalk between
E-cadherin and integrin has been observed previously
in major cellular functions including adhesion, migration,
proliferation and apoptosis [41]. This is not surprising as
both transmembrane adhesion receptors share some com-
mon signaling effector molecules, scaffold and cytoskeletal
proteins, hence the combined ability to influence coordi-
nated regulation of cell-cell and cell-substrate adhesion cru-
cial in normal cell growth and disease state [10,41]. The
decreased substrate adhesion also translated to reduced
cell motility in MCF10A CDH1-/- compared to wildtype
cells. Another E-cadherin depletion study of MCF10A also
showed no gain in cell migration speed [30]. The com-
promised cell-substrate adhesion and migration could
be partially restored when ECM proteins were coated
onto the growth surface, however the downregulation of
talin (encoded by TLN1 and TLN2) and other genes in-
volved in focal adhesion assembly and disassembly like
TNS1, TSN3 and UTRN has probably further compro-
mised traction force [42,43].
The EMT incorporates a series of coordinated events
which involve altered cell-cell and cell-ECM interactions,
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new transcription program to induce and maintain a
mesenchymal phenotype. We found little support for
E-cadherin loss being able to initiate an EMT in a non-
malignant genetic background; deletion of CDH1 from
MCF10A cells was not associated with the reduction in
epithelial markers and the coordinated increase in
mesenchymal markers such as CDH2 [44], nor were
the EMT regulators TWIST1, TWIST2, SNAI1, SNAI2,
ZEB1 and ZEB2 upregulated [9,11,45]. Treatment of
MCF10A cells with either TGF-β or FN caused an
EMT without downregulation of E-cadherin [39,46],
supporting our observations that CDH1 loss does not
drive the EMT in these cells. A recent study done in a
panel of 38 breast cell lines also indicated that E-
cadherin loss is not causal for EMT in human breast
cancer [15].
The only EMT feature that was clearly activated in the
MCF10A CDH1-/- cells was increased expression of sev-
eral metalloprotease genes (MMP9, MMP14, MMP15,
MMP17 and MMP28). Increased expression of MMP2
and MMP9 has been shown previously in MCF10A cells
following TGF-β and ERBB2 induced EMT [47]. We
predict that the impact of elevated MMP expression
would be detectable in invasion assays using 3D matrices
like Matrigel, although such assays were not part of our
analysis. In addition, several genes from the S100A
calcium-binding protein family, S100A7, S100A8 and
S100A9, were also strongly upregulated (≥2 fold) in the
MCF10A CDH1-/- cells. S100A7, while not expressed in
normal epithelia, is frequently seen to be expressed in
pre-invasive ductal carcinoma in situ [48] and is associ-
ated with EMT.
Conclusions
In summary, precise deletion of CDH1 from the non-
tumorigenic breast cell line MCF10A does not enable
anchorage-independent growth, result in neither enhanced
invasiveness in vitro, nor lead to an EMT. However, this
study provides clear evidence for E-cadherin loss promoting
a reduction in cell-substrate adhesion and causing signifi-
cant disruption to the normal organization of the micro-
tubule and actin cytoskeletons.
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